GlassScriptPhysician profile
Mallory Harvin
NPI 1598471534
$2,638.19
in general payments reported to CMS, 2019-2025
13 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $353 · 2024: $2,121 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,471 · Travel and Lodging: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,470.70 |
| Travel and Lodging | $1,167.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,684.71 | 2024 | Axonics |
| Sumitomo Pharma America, INC. | $381.91 | 2023-2025 | Orgovyx, Gemtesa |
| Coloplast Corp | $192.24 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $80.46 | 2023 | Aveed, Xiaflex |
| Abbvie INC. | $56.64 | 2023-2024 | |
| Antares Pharma, INC. | $54.67 | 2024-2025 | Xyosted |
| Procept Biorobotics Corporation | $49.70 | 2024 | Aquabeam System |
| Astellas Pharma US INC | $32.60 | 2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $31.42 | 2024 | |
| Boston Scientific Corporation | $25.93 | 2025 | Axonics |
| Pfizer INC. | $19.10 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $16.33 | 2025 | Rexulti |
| Alpha Cognition USA, INC. | $12.48 | 2025 | Zunveyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Harvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.